Lyra Therapeutics, Inc.
Lyra Therapeutics, Inc. (LYRA) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 100 transactions totaling $87.7M, demonstrating a bullish sentiment with $84.1M in net insider flow. The most recent transaction on Jan 6, 2026 involved a sale of 1,702 shares valued at $5.7K.
LYRA Insider Activity Summary
Who Is Buying LYRA Stock?
No significant insider buying has been recorded for LYRA in the recent period.
Who Is Selling LYRA Stock?
No significant insider selling has been recorded for LYRA in the recent period.
Is Lyra Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LYRA is bullish with an Insider Alignment Score of 98/100 and a net flow of $84.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LYRA Frequently Asked Questions
Understanding LYRA Insider Activity
Insider trading at Lyra Therapeutics, Inc. (LYRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading LYRA stock, having executed 100 transactions in the past 90 days. The most active insider is Advisors Llc Perceptive (Executive), who has made 14 transactions totaling $33.5M.
Related Tools
Track Lyra Therapeutics, Inc. Insider Activity
Get notified when executives and directors at LYRA file new Form 4 transactions